Current:Home > MarketsWhatever happened to the Botswana scientist who identified omicron — then caught it?-DB Wealth Institute B2 Reviews & Ratings
Whatever happened to the Botswana scientist who identified omicron — then caught it?
lotradecoin cryptocurrency exchange View Date:2024-12-25 17:17:34
Sikhulile Moyo led the team of scientists that first identified the omicron variant of COVID-19 in November 2021. It's gone on to dominate the world. Moyo directs the laboratory for the Botswana–Harvard AIDS Institute and is a research associate with the Harvard School of Public Health.
Moyo was disturbed to see the world's reaction to the more transmissible variant. Other nations closed off travel and trade with southern African countries, including Botswana, even as they discovered the variant was already within their own borders. In fact, it was subsequently found that the variant was circulating in the Netherlands a week before the announcement from Africa.
"How do you reward the countries that alert you of a potential dangerous pathogen with travel bans? My country was put on a red list, and I didn't feel good about that," Moyo told NPR.
NPR touched base with Moyo to see what he's been working on – and thinking about – since this landmark discovery.
This interview has been edited for length and clarity.
You discovered omicron. Did omicron discover you?
I got COVID. Funnily enough, the omicron discoverer gets omicron.
I had three days of very serious symptoms of COVID, and I had to stay at home. So I would say mild to severe, but not too severe.
Then I had long COVID. I had almost three months of difficulty trying to recover my lung volume, my breathing. Walking, I was fatigued. All of a sudden, the COVID made my [blood] sugar worse, and I had to change my diabetes doses. I had to step up my meds, because it was no longer controlling [my diabetes] the way it was.
These are the complications that come with COVID, while people think COVID is gone.
Do you think the world has made any progress in learning not to cast blame?
There was a global awakening. Those events around the omicron discovery showed us the triumph of science but the failure of global health policy.
While we suffered, we were a catalyst to make people aware of the value of global public health — that we cannot be inward-looking, because the virus knows no borders.
You see the response to monkeypox is different than the response to COVID. No one is blacklisting anyone from the monkeypox-endemic areas.
Has your work changed because of this discovery — are you and your lab collaborating more with scientists around the world?
Yes! We have established collaborations with the Africa CDC. We've established what is called the Pathogen Genomics Initiative, a network of labs that are working together, and we have a lot of demand for training.
I was named one of the TIME magazine's 100 most influential people of 2022. That gives us a voice to share our experiences but also access to a lot of collaborations that I never thought I would have. That is really pushing us forward.
Have you made more ground-breaking omicron discoveries?
Earlier this year, around April, May, there was the discovery of BA.4 and BA.5, and we detected them in Botswana a few days after South Africa detected them. And these are the variants that have taken over the world. Some of the questions have been: What's happening in southern Africa that [the region] is seemingly detecting more variants?
What is unique about southern Africa, especially Botswana and South Africa, is the ability to detect these variants in near real-time because of the pathogen genomic sequencing that has been established [examining DNA to identify it or see if it's changing]. We think it's not that they are not circulating elsewhere, but it's just that maybe we are looking deeper.
We are always doing pathogen genomic sequencing. The most resourced in the world, in terms of sequencing, is of course the U.K. and the United States, and many parts of Europe. But I think the systematic, real-time, sampling and sequencing [in southern Africa] has been very, very useful.
How has southern Africa become so good at finding new variants and subvariants?
Southern Africa was the hotspot for HIV. We have passed through difficult times. I think we have taken this to our advantage to find solutions for ourselves. With funding — from PEPFAR and from other international agencies, U.S. institutes, some donors — southern Africa began to implement pathogen genomics focusing on HIV.
Some of us were involved in setting up population-based sequencing to understand the movement of viruses, to characterize transmission dynamics — and that has spilled out to malaria, to TB. And we used those technologies to quickly adapt to SARS-CoV-2. That has been the strength of southern Africa.
We're even thinking beyond COVID. We are preparing ourselves to be able to adapt for pathogen discovery. If a [new] outbreak happens, we should be able to quickly check within 24 to 36 hours what it is.
New subvariants seem to be getting better at reinfecting people. What does that mean moving forward?
BA.4 and BA.5 are masters in terms of evading the fury of the immune system. The subvariants were able to elicit an immune response, but magnitudes lower than what we saw before.
As the immunity wanes down, that's where my worry is: How far can we hold on with the current levels of immunity?
The vaccine immunity still provides some protection against severe disease. We know that you may get infected, but you may not get hospitalized with BA.4 and BA.5.
It may get a little bit rough. Many people are spending days at home and [developing] long COVID afterward.
What do you think needs to happen next?
Research, training and development cost a lot of money, but as cases go down, people forget that we need to make sure these systems are sustained. That's one of the challenges: Are we going to be able to sustain some of this innovation that we have developed over a very difficult time of our lives during COVID?
The virus is still finding some pathways to escape immune pressure.
And there's always a possibility of a more virulent variant?
The variant that is going to really dominate is a variant that would have a massive escape to antibody neutralization or to vaccine neutralization. Chances are low of that happening. But omicron taught us that anything can happen.
So we need to be very careful. We need to continue with surveillance, so that if we notice anything, we should be able to go back and say: Do we need to change the way we are doing things?
While I support loosening and going back to our lives [when cases are low], I also feel that's when you need to be more vigilant. When you see signs of wildfire starting, then you can try and put it out.
Melody Schreiber (@m_scribe) is a journalist and the editor of What We Didn't Expect: Personal Stories About Premature Birth.
veryGood! (71423)
Related
- CPI report for July is out: What does latest data mean for the US economy?
- Mark Cuban working on sale of NBA's Mavericks to Sands casino family, AP source says
- Court says prosecutor can’t use statements from teen in school threat case
- Powerball winning numbers for Nov. 27 drawing: Check your tickets for $374 million jackpot
- As Baltimore’s Sewer System Buckles Under Extreme Weather, City Refuses to Help Residents With Cleanup Efforts
- 'If you have a face, you have a place in the conversation about AI,' expert says
- Kendall Jenner, Latto, Dylan Mulvaney, Matt Rife make Forbes 30 Under 30 list
- U.K. leader Rishi Sunak cancels meeting with Greek PM amid diplomatic row over ancient Elgin Marbles
- What to stream: Post Malone goes country, Sydney Sweeney plays a nun and Madden 25 hits the field
- Court says prosecutor can’t use statements from teen in school threat case
Ranking
- What to stream: Post Malone goes country, Sydney Sweeney plays a nun and Madden 25 hits the field
- Coal power, traffic, waste burning a toxic smog cocktail in Indonesia’s Jakarta
- More than half a million people left New York in 2022. Here's where they resettled.
- 3 climate impacts the U.S. will see if warming goes beyond 1.5 degrees
- Rob Schneider Responds to Daughter Elle King Calling Out His Parenting
- What we know as NBA looks into Josh Giddey situation
- Where is parking most expensive? New study shows cheapest, priciest US cities to park in
- Southern California mother charged with drowning 9-year-old daughter in bathtub
Recommendation
-
Hurricane Ernesto aims for Bermuda after leaving many in Puerto Rico without power or water
-
King Charles Wrote Letters to Meghan Markle About Skin Color Comments After Oprah Winfrey Interview
-
Trump loses bid to subpoena Jan. 6 committee material
-
Bobby Petrino returning to Arkansas, this time as offensive coordinator, per report
-
A slain teacher loved attending summer camp. His mom is working to give kids the same opportunity
-
Tennessee governor unveils push for statewide school voucher expansion, no income limitations
-
Charli XCX, The 1975 drummer George Daniel announce engagement: 'For life'
-
Sri Lanka says it struck a deal with creditors on debt restructuring to clear way for IMF funds
Tags
-
lotradecoin trading bot integration
lotradecoin instant crypto swaps
lotradecoin real-time trading charts
lotradecoin developer API documentation
lotradecoin tradingbot
lotradecoin trading with stablecoins
lotradecoin educational resources for traders
lotradecoin leverage trading explained
lotradecoin leverage trading explained